Navigation Links
Video: Jane Seymour Lends Support to Recognise the Hopes and Achievements of People Living With Rheumatoid Arthritis (RA)
Date:9/22/2009

WYETH EUROPA, MAIDENHEAD, UK, Sept. 22 /PRNewswire/ -- Actress, artist and activist Jane Seymour will host the first My Day for RA European event in Barcelona, Spain this evening to recognise the daily challenges, hopes and achievements of people living with rheumatoid arthritis (RA).

To view the Multimedia News Release, go to: http://www.prnewswire.com/mnr/wyeth/40154/

RA is a chronic and progressive disease that can cause pain, deformity, disability and loss of independence without effective management.(1) The My Day for RA event brings together people with RA from all over Europe to share their stories of hope and triumph, and to motivate others with the disease to live life to the fullest.

"I am very proud to be involved in My Day For RA, and am personally inspired by those being honoured today," Jane Seymour says. "Not only does this event recognise and celebrate the achievements of people living with RA, but it encourages everyone with the condition to learn more about their disease and to take an active role in managing their illness."

The My Day for RA event coincides with the recent launch of an online resource - the My Day for RA Action Planner - to help people with RA to understand the impact of their disease, and to develop a straightforward, personalised action plan for the future. The Action Planner is available at www.MyDayforRA.com.

RA affects 2.9 million people across Europe.(1) Most people with RA experience pain and fatigue which can impact every aspect of their lives.(2,3) Daily activities that are often taken for granted, such as getting up in the morning, going to work or caring for one's family can become arduous tasks.

Being a progressive disease means that RA can get worse over time, and eventually lead to permanent and irreversible damage to the joints, which could result in deformity and loss of independence over time, as well as a decreased ability to work, potential surgery and higher medical costs.(2,4,5,6) Studies have shown that early and aggressive treatment of RA may successfully stop disease progression, and enable people with RA to continue living a productive lifestyle.(4,7,8,9)

"Many people with RA expend so much effort on day-to-day living, dealing with the pain and fatigue, that they rarely have time to think about the long-term implications of living with RA," says Dr. Alejandro Olive Marques, Rheumatologist, Hospital Universitari Germans Trias i Pujol, Barcelona, Spain and speaker at the My Day for RA event.

"Fortunately, there have been significant medical advances in the last few years for people with RA. With the right treatment and support, you may not only be able to control your symptoms, but actually stop the disease from getting worse, allowing patients to continue living active lives and protecting their future."

My Day for RA was created by Wyeth Pharmaceuticals. For further information please visit www.MyDayforRA.com.

For further information, interview with a My Day for RA spokesperson or visuals/filmed footage, please contact:

    Wyeth:
    Gill Markham, Communications - Europe, Middle East and Africa
    Direct Tel: +44 (0)162 869 2536
    Mob: +44 (0) 777 082 7753
    Email: markhagl@wyeth.com

    OgilvyHealthPR:
    Nerea Hinzpeter - OgilvyHealthPR
    Tel: + 44 (0) 207 108 6077
    Mob: +44 (0) 7717 320 393
    Email: Nerea.hinzpeter@ohpr.com

Notes to editors:

About the My Day for RA Programme

My Day for RA is a European disease awareness programme, launched in June 2009, that encourages men and women with rheumatoid arthritis (RA) to dedicate a day to learn more about their condition and to set goals in order to feel more confident and empowered to manage their RA now and in the future. Men and women with RA are encouraged to take a day by visiting www.MyDayforRA.com for a downloadable checklist of steps they can take now that may benefit them in the future.

Additionally, people can access the My Day for RA Action Planner, an interactive questionnaire, created to help people with RA to develop a straightforward, personalised, action plan for the future. After using the Action Planner, people are encouraged to follow their personalised plans to achieve the goals they have set for themselves. The Action Planner cannot and should not substitute medical advice: people are encouraged to speak to their doctor for valuable guidance on how to best manage their RA to meet the goals they have set.

About Rheumatoid Arthritis

Rheumatoid Arthritis is a chronic condition that typically affects the hands, wrists and feet, and may also affect the knees, hips and shoulders. If the condition persists over time, it can cause permanent damage, including tendon, ligament, cartilage and bone destruction and deformity.(2,3)

About WYETH

Wyeth Pharmaceuticals, a division of Wyeth, has leading products in the areas of women's health care, infectious disease, gastrointestinal health, central nervous system, inflammation, transplantation, hemophilia, oncology, vaccines and nutritional products.

Wyeth is one of the world's largest research-driven pharmaceutical and health care products companies. It is a leader in the discovery, development, manufacturing and marketing of pharmaceuticals, vaccines, biotechnology products, nutritionals and non-prescription medicines that improve the quality of life for people worldwide. The Company's major divisions include Wyeth Pharmaceuticals, Wyeth Consumer Healthcare and Fort Dodge Animal Health.

REFERENCES:

1. "Prevalence and Impact of Rheumatoid Arthritis." Amgen Rheumatology Inflammation Service Europe (RISE). Available athttp://www.kineret-eu.com/en/pro/rhe/rhepre.jsp. Last Accessed May 2009

2. "What is RA?" National Rheumatoid Arthritis Society (NRAS) Website. Available athttp://www.rheumatoid.org.uk/article.php?article_id=224. Last Accessed May 2009

3. Lee DM. et al. Rheumatoid arthritis. The Lancet. 2001;358:903-911

4. Weaver AL. et al. The Impact of new biologicals in the treatment of rheumatoid arthritis. Rheumatology. 2004;43(Suppl.3):iii17 iii23

5. Sokka T. et al. Work disability in early rheumatoid arthritis. Clin Exp Rheum. 2003;21 (Suppl.31) S71-S74

6. Burton W. et al. Systematic review of studies of productivity loss due to rheumatoid arthritis. Occup Med. 2006:56:18-27

7. Emery, P. et al Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trial. The Lancet. 2008; 372: 375-382

8. Breedveld FC. et al. The PREMIER study: A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment. Arthritis Rheum. 2006;54:26-37

9. Korpela M. et al. Retardation of joint damage in patients with early rheumatoid arthritis by initial aggressive treatment with disease-modifying antirheumatic drugs. Five year experience from the FIN-RACo study. Arthritis Rheum. 2004; 50:2072-2081

My Day for RA was created by Wyeth Pharmaceuticals

EU-ENB-210709


'/>"/>
SOURCE Wyeth
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Video: The Depend Campaign to End Prostate Cancer Brings Sports Legends Together to Celebrate National Prostate Cancer Awareness Month
2. Video: NFL Season Kicks Off With Campaign to Know Your Stats About Prostate Cancer
3. Video: Members of Congress Receive Legislative Awards From National Amputee Organizations
4. Video: Teen Girls Less Active, but Triple Play Program Bucks Trend
5. Video: Yoplait(R) and Celebrity Breast Cancer Surgeon Dr. Kristi Funk Emphasize Importance of Early Detection and Risk Reduction
6. Video: Color of Hope: Because All Women Are Worth It
7. Video: Seventh Annual Avon Walk for Breast Cancer Los Angeles Raises More Than $4.6 Million
8. Video: New United States Potato Board Quick And Healthy Recipes Highlight the Convenient, Nutritious and Budget-Friendly Potato
9. Video: Edie Falco and Cynthia Nixon Appear in New Stand Up To Cancer(TM) PSAs Designed to Educate Cancer Patients About the Importance Of Lowering Ones Risk of Infection During Treatment
10. Video: U.S. Department of Health and Human Services Joins Ad Council and Warner Bros. Pictures to Combat Childhood Overweight and Obesity
11. Video: Home-Spun or Hard Fact?
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... , ... Global law firm Greenberg Traurig, P.A. announced that 20 Florida attorneys ... peers for this recognition are considered among the top 2 percent of lawyers practicing ... members of this year’s Legal Elite Hall of Fame: Miami Shareholders Mark D. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, CA ... the Road To Recovery® program to drive cancer patients to and from their cancer ... ensure the highest quality of life and ongoing independence. Getting to and from ...
(Date:6/24/2016)... TX (PRWEB) , ... June 24, 2016 , ... People ... part in Genome magazine’s Code Talker Award, an essay contest in which patients and ... an award to be presented at the 2016 National Society of Genetic Counselors (NSGC) ...
(Date:6/24/2016)... ... 24, 2016 , ... The Haute Beauty Network, affiliated with ... as a prominent plastic surgeon and the network’s newest partner. , Dr. ... handsome men, look naturally attractive. Plastic surgery should be invisible.” He stands by ...
(Date:6/24/2016)... Maryland (PRWEB) , ... June 24, 2016 , ... ... Angels is actively feeding the Frederick area economy by obtaining investment capital for ... over the past 2½ years that have already resulted in more than a ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... OTTAWA, Ontario , June 27, 2016  VMS ... the Company,s Board will take whatever measures required to ... the Company,s stock which is currently listed on the ... S Wexler, Company Chairman and CEO, "We are seeing ... be difficult to understand, not only by the Company, ...
(Date:6/24/2016)... June 24, 2016  Global Blood Therapeutics, Inc. (GBT) ... developing novel therapeutics for the treatment of grievous ... the closing of its previously announced underwritten public ... the public offering price of $18.75 per share. ... offered by GBT. GBT estimates net proceeds from ...
(Date:6/24/2016)... Va. , June 24, 2016 The ... set of recommendations that would allow biopharmaceutical ... (HCEI) with entities that make formulary and coverage decisions, ... the "value" of new medicines. The recommendations ... does not appear on the drug label, a prohibition ...
Breaking Medicine Technology: